EGFR and neoplasm: Importantly, EVs isolated from the blood, saliva, or other body fluids of patients with HNCs have been shown to carry tumor-specific molecular signatures, including PD-L1, EGFR, and non-coding RNAs, which correlate with disease stage and treatment response [173, 174].